Zydus Cadila gets USFDA nod to market 20 and 40 mg Eletripta
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Zydus Cadila has received the final approval from USFDA to market 20 mg (base) and 40 mg (base) Eletriptan Hydrobromide tablets which are used in the treatment of migraine...


http://bit.ly/2sNB9qc
Dr. T●●●j S●●●●●i and 6 others like this
Like
Comment
Share